BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12954113)

  • 1. Evaluation of C-5 propynyl pyrimidine-containing oligonucleotides in vitro and in vivo.
    Shen L; Siwkowski A; Wancewicz EV; Lesnik E; Butler M; Witchell D; Vasquez G; Ross B; Acevedo O; Inamati G; Sasmor H; Manoharan M; Monia BP
    Antisense Nucleic Acid Drug Dev; 2003; 13(3):129-42. PubMed ID: 12954113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivo.
    Prakash TP; Johnston JF; Graham MJ; Condon TP; Manoharan M
    Nucleic Acids Res; 2004; 32(2):828-33. PubMed ID: 14762210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals.
    Swayze EE; Siwkowski AM; Wancewicz EV; Migawa MT; Wyrzykiewicz TK; Hung G; Monia BP; Bennett CF
    Nucleic Acids Res; 2007; 35(2):687-700. PubMed ID: 17182632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts.
    Burel SA; Hart CE; Cauntay P; Hsiao J; Machemer T; Katz M; Watt A; Bui HH; Younis H; Sabripour M; Freier SM; Hung G; Dan A; Prakash TP; Seth PP; Swayze EE; Bennett CF; Crooke ST; Henry SP
    Nucleic Acids Res; 2016 Mar; 44(5):2093-109. PubMed ID: 26553810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligonucleotides containing conformationally constrained 2',4'-(N-methoxy)aminomethylene and 2',4'-aminooxymethylene and 2'-O,4'-C-aminomethylene bridged nucleoside analogues show improved potency in animal models.
    Prakash TP; Siwkowski A; Allerson CR; Migawa MT; Lee S; Gaus HJ; Black C; Seth PP; Swayze EE; Bhat B
    J Med Chem; 2010 Feb; 53(4):1636-50. PubMed ID: 20108935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short antisense oligonucleotides with novel 2'-4' conformationaly restricted nucleoside analogues show improved potency without increased toxicity in animals.
    Seth PP; Siwkowski A; Allerson CR; Vasquez G; Lee S; Prakash TP; Wancewicz EV; Witchell D; Swayze EE
    J Med Chem; 2009 Jan; 52(1):10-3. PubMed ID: 19086780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing in vitro and in vivo activity of 2'-O-[2-(methylamino)-2-oxoethyl]- and 2'-O-methoxyethyl-modified antisense oligonucleotides.
    Prakash TP; Kawasaki AM; Wancewicz EV; Shen L; Monia BP; Ross BS; Bhat B; Manoharan M
    J Med Chem; 2008 May; 51(9):2766-76. PubMed ID: 18399648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2'-O-(2-methoxy)ethyl chemistry.
    Zellweger T; Miyake H; Cooper S; Chi K; Conklin BS; Monia BP; Gleave ME
    J Pharmacol Exp Ther; 2001 Sep; 298(3):934-40. PubMed ID: 11504787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical and antisense properties of oligodeoxynucleotides containing 7-propynyl-, 7-iodo- and 7-cyano-7-deaza-2-amino-2'-deoxyadenosines.
    Balow G; Mohan V; Lesnik EA; Johnston JF; Monia BP; Acevedo OL
    Nucleic Acids Res; 1998 Jul; 26(14):3350-7. PubMed ID: 9649618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of base modifications on antisense properties of 2'-O-methoxyethyl and PNA oligonucleotides.
    Sazani P; Astriab-Fischer A; Kole R
    Antisense Nucleic Acid Drug Dev; 2003; 13(3):119-28. PubMed ID: 12954112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. True antisense oligonucleotides with modified nucleotides restricted in the N-conformation.
    Koizumi M
    Curr Top Med Chem; 2007; 7(7):661-5. PubMed ID: 17430207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular penetration and antisense activity by a phenoxazine-substituted heptanucleotide.
    Flanagan WM; Wagner RW; Grant D; Lin KY; Matteucci MD
    Nat Biotechnol; 1999 Jan; 17(1):48-52. PubMed ID: 9920268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Toxicity Assessment of 2'-O-Methoxyethyl Antisense Oligonucleotides in Mice.
    Zanardi TA; Kim TW; Shen L; Serota D; Papagiannis C; Park SY; Kim Y; Henry SP
    Nucleic Acid Ther; 2018 Aug; 28(4):233-241. PubMed ID: 29708844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of the toxicological effects of a novel constrained ethyl modified antisense compound targeting signal transducer and activator of transcription 3 in mice and cynomolgus monkeys.
    Burel SA; Han SR; Lee HS; Norris DA; Lee BS; Machemer T; Park SY; Zhou T; He G; Kim Y; MacLeod AR; Monia BP; Lio S; Kim TW; Henry SP
    Nucleic Acid Ther; 2013 Jun; 23(3):213-27. PubMed ID: 23692080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antisense properties of 2'-O-(2S-methoxypropyl)-RNA-modified gapmer antisense oligonucleotides.
    Yu J; Pandey SK; Khatri H; Prakash TP; Swayze EE; Seth PP
    ChemMedChem; 2014 Sep; 9(9):2040-4. PubMed ID: 24891270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and cellular activity of stereochemically-pure 2'-O-(2-methoxyethyl)-phosphorothioate oligonucleotides.
    Li M; Lightfoot HL; Halloy F; Malinowska AL; Berk C; Behera A; Schümperli D; Hall J
    Chem Commun (Camb); 2017 Jan; 53(3):541-544. PubMed ID: 27966701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo antisense activity of ENA oligonucleotides targeting PTP1B mRNA in comparison of that of 2'-MOE-modified oligonucleotides.
    Koizumi M; Takagi-Sato M; Okuyama R; Araki K; Sun W; Nakai D
    Nucleic Acids Symp Ser (Oxf); 2007; (51):111-2. PubMed ID: 18029611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense properties of 2'-O-dimethylaminooxyethyl (2'-O-DMAOE) oligonucleotides.
    Prakash TP; Kawasaki AM; Johnston JF; Graham MJ; Condon TP; Manoharan M
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):829-32. PubMed ID: 11563125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligonucleotides Containing C5-Propynyl Modified Arabinonucleic Acids: Synthesis, Biophysical and Antisense Properties.
    Pontarelli A; Wilds CJ
    Chembiochem; 2023 May; 24(9):e202300068. PubMed ID: 36857293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hepatotoxicity of 2' fluoro-modified 5-10-5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteins.
    Shen W; De Hoyos CL; Sun H; Vickers TA; Liang XH; Crooke ST
    Nucleic Acids Res; 2018 Mar; 46(5):2204-2217. PubMed ID: 29390093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.